stockportfolio.pro
OrthoPediatrics Corp. (KIDS)
Healthcare · Medical Devices · NasdaqGM
OrthoPediatrics Corp. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37.30M | $45.62M | $57.56M | $72.55M | $71.08M | $98.05M | $122.29M | $148.73M | $204.73M | $236.35M |
| Gross profit | $26.37M | $34.45M | $42.68M | $54.62M | $55.03M | $73.40M | $90.66M | $111.25M | $148.60M | $172.66M |
| Net income | $-6.57M | $-8.93M | $-12.03M | $-13.73M | $-32.94M | $-16.26M | $1.26M | $-20.97M | $-37.82M | $-39.65M |
| Net margin | -17.6% | -19.6% | -20.9% | -18.9% | -46.3% | -16.6% | 1.0% | -14.1% | -18.5% | -16.8% |
Source: OrthoPediatrics Corp. SEC filings (10-K). 11 years of history available in the interactive view.
Explore 11 years of OrthoPediatrics Corp. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track KIDS in your portfolio →
OrthoPediatrics Corp. financial history by metric
About OrthoPediatrics Corp.
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
OrthoPediatrics Corp. — frequently asked questions
What is OrthoPediatrics Corp.'s revenue?
OrthoPediatrics Corp. (KIDS) reported revenue of $236.35M for fiscal year 2025, up 15.4% from the prior year, according to its SEC filings.
Is OrthoPediatrics Corp. profitable?
No — KIDS reported a net loss of $-39.65M in fiscal 2025.
What is KIDS's P/E ratio?
OrthoPediatrics Corp. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is OrthoPediatrics Corp. growing?
KIDS's revenue grew at roughly 27.2% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does OrthoPediatrics Corp. have?
As of fiscal year 2025, KIDS carried roughly $99.99M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is OrthoPediatrics Corp.'s gross margin?
KIDS's gross margin was 73.1% in fiscal 2025 — gross profit of $172.66M on revenue of $236.35M.
What is OrthoPediatrics Corp.'s market cap?
OrthoPediatrics Corp. (KIDS) has a market capitalization of about $465.67M, based on the latest data in our nightly-refreshed cache.
When does OrthoPediatrics Corp.'s fiscal year end?
KIDS's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from OrthoPediatrics Corp.'s official SEC filings (10-K and 10-Q), covering 11 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.